Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities

6 Months Ended

Jun. 30, 2012

4. Accrued Liabilities

Accrued expenses consisted of the following:


($ in thousands)	As of June 30, 2012		As of December 31, 2011
Salaries, bonuses and related benefits	$	640	$	493
Professional fees		306		215
Research and development expenses		291		653
Accrued milestones		1,846		1,500
Other		71		38

Total accrued expenses	$	3,154	$	2,899

Accrued milestones at June 30, 2012 and December 31, 2011 include $1.8 million and $1.5 million, respectively, due to OvaMed.